Literature DB >> 3598401

High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids.

S S Rossi, J L Converse, A F Hofmann.   

Abstract

A reversed phase high pressure liquid chromatography (HPLC) system capable of simultaneously separating four lithocholyl species (sulfated and unsulfated forms of lithocholylglycine and lithocholyltaurine) as well as the eight other major conjugated bile acids present in human bile is described. The system uses a C18 octadecylsilane column and isocratic elution with methanol phosphate buffer, pH 5.35. Relative bile acid concentration is determined by absorbance at 200 nm. Retention times relative to chenodeoxycholylglycine are reported for the four lithocholic acid forms, the glycine and taurine amidate of the four major bile acids present in human bile (cholic, chenodeoxycholic, ursodeoxycholic, and deoxycholic), and for their corresponding unconjugated forms. Retention times are also reported for the glycine and taurine amidates as well as the unconjugated form of the C23 norderivatives of these bile acids. Maximal absorbance of bile acid amidates is at 200 nm and is very similar for the (unsulfated) glycine and taurine amidates. Sulfated lithocholyl amidates exhibit molar absorptivities at 200 nm which are 1.4 times greater than that of non-sulfated lithocholyl amidates. Unconjugated bile acid absorbance at 200 nm or 210 nm is 20 to 30 times less than that of corresponding peptide conjugates. The method has been applied to samples of gallbladder bile obtained from 14 healthy subjects to define the pattern of conjugated bile acids present in human bile.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3598401

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  56 in total

1.  Use of a fluorescent bile acid to enhance visualization of the biliary tract and bile leaks during laparoscopic surgery in rabbits.

Authors:  F Holzinger; L Krähenbühl; C D Schteingart; H T Ton-Nu; A F Hofmann
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

2.  Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Frank Lammert; Anne Schmitz; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2010-04-28       Impact factor: 4.686

3.  Protective effects of nonionic triblock copolymers on bile acid-mediated epithelial barrier disruption.

Authors:  Adam Edelstein; David Fink; Mark Musch; Vesta Valuckaite; Olga Zaborina; Simonida Grubjesic; Millicent A Firestone; Jeffrey B Matthews; John C Alverdy
Journal:  Shock       Date:  2011-11       Impact factor: 3.454

4.  Primary intrahepatic cholesterol stones. Report of one case and treatment with ursodeoxycholic acid.

Authors:  Y Schillio; G Amouyal; B Gayet; M Dumont; C Degott; S Erlinger
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

5.  Two farnesoid X receptor alpha isoforms in Japanese medaka (Oryzias latipes) are differentially activated in vitro.

Authors:  Deanna L Howarth; Lee R Hagey; Sheran H W Law; Ni Ai; Matthew D Krasowski; Sean Ekins; John T Moore; Erin M Kollitz; David E Hinton; Seth W Kullman
Journal:  Aquat Toxicol       Date:  2010-03-01       Impact factor: 4.964

6.  The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2016-01-12       Impact factor: 4.686

7.  Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.

Authors:  G A Clarke; G Bouchard; B Paigen; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress.

Authors:  Carlos Felipe Bernardes-Silva; Adérson O M C Damião; Aytan M Sipahi; Francisco R M Laurindo; Kiyoshi Iriya; Fabio P Lopasso; Carlos A Buchpiguel; Maria Laura L Lordello; Carmem L O Agostinho; Antonio A Laudanna
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 9.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

10.  Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Authors:  R A Jorgensen; E R Dickson; A F Hofmann; S S Rossi; K D Lindor
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.